Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones in Ph+ ALL
NCT03007147Phase 3Active, not recruiting
- Sponsor
- Children's Oncology Group
- Start
- Aug 2017
- Primary completion
- Jun 2026
- Countries
- 19
01
Overview
A Phase 3 trial of imatinib in acute lymphoblastic leukemia (ALL), sponsored by Children's Oncology Group. Started Aug 2017; status: active, not recruiting.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT03007147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03007147.